Organization
Tianjin Medical University General Hospital, Tianjin, China
5 abstracts
Abstract
Neoadjuvant toripalimab plus chemotherapy for resectable stage II-IIIB non-squamous non-small cell lung cancer with EGFR mutations: A multi-center, multi-cohort, exploratory study.Org: Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China, Department of Thoracic Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Department of Thoracic Surgery, China Aerospace Science & Industry Corporation 731 Hospital, Beijing, China, Department of Thoracic Surgery, Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China, Tianjin Medical University General Hospital, Tianjin, China,
Abstract
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI study): A prospective, single-arm, phase II trial.Org: Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China, Tongji Medical College Huazhong University of Science and Technology, Huazhong University of Science and Technology Union Shenzhen Hospital, Wuhan, China, Women's Hospital School of Medicine Zhejiang University,
Abstract
Efficacy and safety of first-line immunotherapy for advanced gastric or gastroesophageal cancer: System review network meta-analysis.Org: Tianjin Medical University General Hospital, Tianjin, China, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,
Abstract
The impact of SARS-CoV2 Omicron variants epidemic on patients with cancer in China.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Tianjin Medical University General Hospital, Tianjin, China, Tianjin Hemay Pharmaceutical, China National Biotec Group,
Abstract
A survey on the detection of HPD-related genes by liquid biopsy in patients with lung cancer in China.Org: Tianjin Medical University General Hospital, Tianjin, China, HaploX Biotechnology, Shenzhen, China, HaploX Biotechnology Co. Ltd.,